IL219834A0 - Melanoma specific biomarker - Google Patents

Melanoma specific biomarker

Info

Publication number
IL219834A0
IL219834A0 IL219834A IL21983412A IL219834A0 IL 219834 A0 IL219834 A0 IL 219834A0 IL 219834 A IL219834 A IL 219834A IL 21983412 A IL21983412 A IL 21983412A IL 219834 A0 IL219834 A0 IL 219834A0
Authority
IL
Israel
Prior art keywords
specific biomarker
melanoma specific
melanoma
biomarker
specific
Prior art date
Application number
IL219834A
Other languages
English (en)
Original Assignee
Univ Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Surrey filed Critical Univ Surrey
Publication of IL219834A0 publication Critical patent/IL219834A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL219834A 2009-12-04 2012-05-16 Melanoma specific biomarker IL219834A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921329.9A GB0921329D0 (en) 2009-12-04 2009-12-04 Biomarker
PCT/GB2010/001334 WO2011067549A1 (en) 2009-12-04 2010-07-13 Melanoma specific biomarker

Publications (1)

Publication Number Publication Date
IL219834A0 true IL219834A0 (en) 2012-07-31

Family

ID=41641989

Family Applications (1)

Application Number Title Priority Date Filing Date
IL219834A IL219834A0 (en) 2009-12-04 2012-05-16 Melanoma specific biomarker

Country Status (14)

Country Link
US (1) US20120263654A1 (enExample)
EP (1) EP2507384A1 (enExample)
JP (1) JP2013512668A (enExample)
CN (1) CN102791878A (enExample)
AU (1) AU2010326433A1 (enExample)
BR (1) BR112012013041A2 (enExample)
CA (1) CA2782034A1 (enExample)
GB (1) GB0921329D0 (enExample)
IL (1) IL219834A0 (enExample)
IN (1) IN2012DN04381A (enExample)
MX (1) MX2012006229A (enExample)
RU (1) RU2012121096A (enExample)
WO (1) WO2011067549A1 (enExample)
ZA (1) ZA201203517B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2294216A4 (en) 2008-05-14 2011-11-23 Dermtech Int DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY ANALYSIS OF NUCLEIC ACIDS
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
WO2016168174A1 (en) * 2015-04-13 2016-10-20 The Translational Genomics Research Institute Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies
JP2018518203A (ja) * 2015-06-24 2018-07-12 オックスフォード バイオダイナミックス リミテッド エピジェネティックな染色体相互作用
KR101777085B1 (ko) * 2017-02-23 2017-09-11 주식회사 성균바이오텍 En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
RU2766739C1 (ru) * 2021-04-12 2022-03-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) Способ прогноза эффективности терапии меланомы

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
US7960110B2 (en) * 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
WO2009131733A1 (en) * 2008-04-21 2009-10-29 The Trustees Of Columbia University In The City Of New York Gab2 amplification in melanoma

Also Published As

Publication number Publication date
BR112012013041A2 (pt) 2016-10-11
CA2782034A1 (en) 2011-06-09
WO2011067549A1 (en) 2011-06-09
JP2013512668A (ja) 2013-04-18
AU2010326433A1 (en) 2012-06-07
ZA201203517B (en) 2013-02-27
US20120263654A1 (en) 2012-10-18
MX2012006229A (es) 2012-06-19
GB0921329D0 (en) 2010-01-20
EP2507384A1 (en) 2012-10-10
CN102791878A (zh) 2012-11-21
RU2012121096A (ru) 2014-01-10
IN2012DN04381A (enExample) 2015-08-07

Similar Documents

Publication Publication Date Title
EP2373999A4 (en) NEW BIOMARKERS
ZA201109437B (en) Novel azabicyclohexanes
IL214232A0 (en) Novel tricyanoborates
GB201021502D0 (en) Biomarkers
GB201008340D0 (en) Biomarkers
GB201018056D0 (en) Biomarkers
IL219834A0 (en) Melanoma specific biomarker
GB201004442D0 (en) Biomarker
GB0903417D0 (en) Biomarkers
GB0818660D0 (en) Biomarkers
ZA201105184B (en) Biomarker
GB201005561D0 (en) Biomarkers
GB201001444D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
GB0915736D0 (en) Biomarkers
GB201010316D0 (en) Biomarkers
GB201005456D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
IL217333A0 (en) Biomarker
GB0903391D0 (en) Biomarkers
GB0912175D0 (en) Biomarker
GB201001419D0 (en) Biomarkers
GB0922236D0 (en) Biomarkers
GB201008727D0 (en) Biomarkers
GB0915278D0 (en) Biomarker